Evidence map›Paper›PMID 37520220›Full record

ArticleFrontiers in psychiatry2023

Demonstration of an app-delivered digital therapeutic program for methamphetamine use disorder.

Kristin Muhlner, Jeff DeFlavio, Alfonso Ang, Michael Zito, A Thomas McLellan, Brian Perrochet

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kristin MuhlnerAffect Therapeutics, Inc., New York, NY, United States.
Jeff DeFlavioAffect Therapeutics, Inc., New York, NY, United States.
Alfonso AngUCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA, United States.
Michael ZitoUCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA, United States.
A Thomas McLellanTreatment Research Institute, Research Park, NC, United States.
Brian PerrochetUCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA, United States.
Neurobehavioral Systems · USTreatment Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study assessed the feasibility and utility of a digital, all-virtual program designed for treatment of methamphetamine use disorder (MUD). Forty-nine adults with moderate- to severe-level MUD (per DSM-5 criteria) commenced the 8-week intervention. All aspects of the program were delivered via smartphone-based app. Intervention components included counseling (cognitive behavioral therapy in group and individual sessions), app-based therapeutic tasks, remote biological drug testing, medical oversight by psychiatrists/nurse practitioners, and contingency management procedures (including rewards for methamphetamine-free saliva drug tests, accomplishing tasks, and engaging in assigned activities). Of the 49 participants who commenced treatment, 27 participants (55%) completed the program. Repeated-measures mixed-model analyses show that participants were more likely to test negative for meth use from week 1 to week 8 (OR = 1.57, 95% CI [1.28, 1.97];

Indexed as

appcontingency managementcravingdigital healthmethamphetamineoutcomessubstance use disorder

Identifiers

PMID37520220
PMCPMC10373299
OpenAlexW4384199939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.